COLINZ LABORATORIES LTD. has reported Standalone financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 1.9224 crores during the period ended March 31, 2026 as compared to Rs. 1.50905 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 0.1712 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 0.0836 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 0.68 for the period ended March 31, 2026 as compared to Rs. 0.33 for the period ended December 31, 2025.
| Total Income | ₹ 1.9224 crs | ₹1.50905 crs | 27.39% |
| Net Profit | ₹0.1712 crs | ₹0.0836 crs | 104.78% |
| EPS | ₹0.68 | ₹0.33 | 106.06% |
Financial Results (Q4 FY2026) - YoY Comparison The company has reported total income of Rs. 1.9224 crores during the period ended March 31, 2026 as compared to Rs.1.5270 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.0.1712 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.0.1504 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.0.68 for the period ended March 31, 2026 as compared to Rs.0.60 for the period ended March 31, 2025.
| Total Income | ₹ 1.9224 crs | ₹1.5270 crs | 25.89% |
| Net Profit | ₹0.1712 crs | ₹0.1504 crs | 13.83% |
| EPS | ₹0.68 | ₹0.60 | 13.33% |
Financial Results (Year Ended FY2026) - YoY Comparison The company has reported total income of Rs.6.6205 crores during the Financial Year ended March 31, 2026 as compared to Rs.6.8256 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.0.5145 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.0.4966 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.2.04 for the Financial Year ended March 31, 2026 as compared to Rs.1.97 for the Financial Year ended March 31, 2025.
| Total Income | ₹6.6205 crs | ₹6.8256 crs | -3.00% |
| Net Profit | ₹0.5145 crs | ₹0.4966 crs | 3.60% |
| EPS | ₹2.04 | ₹1.97 | 3.55% |
Shares of COLINZ LABORATORIES LTD. was last trading in BSE at Rs. 47.84 as compared to the previous close of Rs. 46.00. The total number of shares traded during the day was 2987 in over 20 trades.
The stock hit an intraday high of Rs. 47.99 and intraday low of 43.76. The net turnover during the day was Rs. 138917.00.
Source : Equity Bulls
Keywords
ColinzLaboratories
Q4FY26
Q4FY2026
FY26
FY2026
ResultUpdate